An experimental drug stops advanced breast cancer from progressing in some people with tumors that have grown resistant to ...

A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen ...

From life-saving medicine to gratitude for caregivers and a surprise romance, these stories remind us of the power of human connection.